Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Roche
Biotech
Genentech pays Alector $100M for preclinical Parkinson’s asset
Genentech is committing up to $1.17 billion in milestones and tiered royalties on net sales.
Nick Paul Taylor
Oct 5, 2026 10:09am
Roche launches new screening test for SMA, SCID and SCD
Oct 1, 2026 9:36am
Genentech's CEO on the next 50 years of the original biotech
Oct 1, 2026 8:00am
Roche, Zealand see phase 2 amylin weight loss peak at mid-dose
Sep 30, 2026 4:57am
Roche drops obesity antibody after flunked interim analysis
Sep 28, 2026 11:03am
Travere chief makes way for former Amicus CEO—Chutes & Ladders
Sep 25, 2026 8:30am